Kapusta Matthew C 4
4 · uniQure N.V. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
uniQure (QURE) CEO Matthew Kapusta Receives RSUs; Sells Shares
What Happened
Matthew C. Kapusta, CEO and Managing Director of uniQure (QURE), received two awards on 2026-03-04: 70,600 restricted share units (RSUs) and 113,800 derivative awards (stock option/other derivative) — both granted at $0.00. On the same date he disposed of 14,581 shares in an open-market sale at a weighted average price of $9.06 for total proceeds of approximately $132,104. The sale was executed automatically to cover estimated withholding taxes and was not a discretionary trade.
Key Details
- Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (appears timely).
- Grants: 70,600 RSUs (F1) and 113,800 derivative award (stock option per F4), both reported as acquisitions at $0.00.
- Sale: 14,581 shares sold (S) at a weighted average price of $9.06, proceeds ≈ $132,104; sale prices ranged $9.00–$9.22 (F3).
- Reason for sale: automatic sale upon RSU vesting to cover withholding taxes (F2) — tax withholding, not a discretionary sale.
- Vesting notes: RSUs vest in 1/3 increments annually starting one year from grant (F1). The derivative/option vests 25% at year one then 6.25% quarterly thereafter (F4).
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
Context
- For retail investors: this filing mainly shows equity compensation being granted and an automatic sell-to-cover for taxes. Such automatic sales on vesting are routine and do not necessarily signal the insider’s market view.
- No open-market purchases were reported; purchases are generally more informative about insider bullishness.
- The derivative award is a future-vesting instrument (option/award) and does not represent immediately tradable shares until vested and, if applicable, exercised.
Insider Transaction Report
Form 4
uniQure N.V.QURE
Kapusta Matthew C
DirectorCEO, Managing Director
Transactions
- Award
Ordinary Shares
[F1]2026-03-04+70,600→ 675,239 total - Sale
Ordinary Shares
[F2][F3]2026-03-04$9.06/sh−14,581$132,104→ 660,658 total - Award
Stock Option (Right to Buy)
[F4]2026-03-04+113,800→ 113,800 totalExercise: $9.04Exp: 2036-03-04→ Ordinary Shares (113,800 underlying)
Footnotes (4)
- [F1]Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.
- [F2]The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- [F4]The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.
Signature
/s/ Christian Klemt, Attorney-in-Fact|2026-03-06